Advertisement

Topics

ARCA biopharma Announces GENETIC-AF Data And Safety Monitoring Board Recommendation To Complete Phase 2B GENETIC-AF Clinical Trial Based On Efficacy And Safety Data In Phase IIB Interim Analysis

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: ARCA biopharma Announces GENETIC-AF Data And Safety Monitoring Board Recommendation To Complete Phase 2B GENETIC-AF Clinical Trial Based On Efficacy And Safety Data In Phase IIB Interim Analysis

NEXT ARTICLE

More From BioPortfolio on "ARCA biopharma Announces GENETIC-AF Data And Safety Monitoring Board Recommendation To Complete Phase 2B GENETIC-AF Clinical Trial Based On Efficacy And Safety Data In Phase IIB Interim Analysis"

Quick Search
Advertisement